MiR-92a-2-5p suppresses esophageal squamous cell carcinoma cell proliferation and invasion by targeting PRDX2

被引:3
作者
Zhan, Xiang [1 ]
Li, Jixian [1 ]
Zeng, Renya [2 ]
Lei, Lingli [1 ]
Feng, Alei [2 ]
Yang, Zhe [1 ,2 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Tumor Res & Therapy Ctr, Jinan 250021, Shandong, Peoples R China
[2] Shandong Univ, Tumor Res & Therapy Ctr, Shandong Prov Hosp, Jinan 250021, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
MiRNA; Esophageal squamous cell carcinoma; Peroxiredoxin2; Protein kinase B/mammalian target of; rapamycin; Wnt/beta-catenin; PEROXIREDOXINS; MICRORNAS;
D O I
10.1016/j.yexcr.2024.113925
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) can function as negative regulators of gene expression by binding to the 3 '-untranslated region (3 '-UTR) of target genes. The aberrant expression of miRNAs in neoplasm is extensively associated with tumorigenesis and cancer progression, including esophageal squamous cell carcinoma (ESCC). Our previous investigation has identified the oncogenic roles of Peroxiredoxin2 (PRDX2) in ESCC progression; however, its upstream regulatory mechanism remains to be elucidated. By merging the prediction results from miRWalk2.0 and miRNA differential expression analysis results based on The Cancer Genome Atlas Esophageal Carcinoma (TCGA-ESCA) database, eight miRNA candidates were predicted to be the potential regulatory miRNAs of PRDX2, followed by further identification of miR-92a-2-5p as the putative miRNA of PRDX2. Subsequent functional studies demonstrated that miR-92a-2-5p can suppress ESCC cell proliferation and migration, as well as tumor growth in subcutaneous tumor xenograft models, which might be mediated by the suppression of AKT/mTOR and Wnt3a/beta-catenin signaling pathways upon miR-92a-2-5p mimic transfection condition. These data revealed the tumor suppressive functions of miR-92a-2-5p in ESCC by targeting PRDX2.
引用
收藏
页数:9
相关论文
共 44 条
[31]  
Sagach V.F., 1978, Fiziol. Zh., V35, P15
[32]   HCV Infection and Miravirsen [J].
Sanchez-Nino, Maria D. ;
Ortiz, Alberto .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (09) :877-878
[33]   A machine learning approach identified a diagnostic model for pancreatic cancer through using circulating microRNA signatures [J].
Savareh, Behrouz Alizadeh ;
Aghdaie, Hamid Asadzadeh ;
Behmanesh, Ali ;
Bashiri, Azadeh ;
Sadeghi, Amir ;
Zali, Mohammadreza ;
Shams, Roshanak .
PANCREATOLOGY, 2020, 20 (06) :1195-1204
[34]  
Short MW, 2017, AM FAM PHYSICIAN, V95, P22
[35]   Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs [J].
Stresing, V. ;
Baltziskueta, E. ;
Rubio, N. ;
Blanco, J. ;
Arriba, Ma C. ;
Valls, J. ;
Janier, M. ;
Clezardin, P. ;
Sanz-Pamplona, R. ;
Nieva, C. ;
Marro, M. ;
Dmitri, P. ;
Sierra, A. .
ONCOGENE, 2013, 32 (06) :724-735
[36]   Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Sung, Hyuna ;
Ferlay, Jacques ;
Siegel, Rebecca L. ;
Laversanne, Mathieu ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin ;
Bray, Freddie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (03) :209-249
[37]   Prx2 (Peroxiredoxin 2) as a Cause of Hydrocephalus After Intraventricular Hemorrhage [J].
Tan, Xiaoxiao ;
Chen, Jingyin ;
Keep, Richard F. ;
Xi, Guohua ;
Hua, Ya .
STROKE, 2020, 51 (05) :1578-1586
[38]  
Tüfekci KU, 2014, METHODS MOL BIOL, V1107, P33, DOI 10.1007/978-1-62703-748-8_3
[39]   Cancer Hallmarks and MicroRNAs: The Therapeutic Connection [J].
Van Roosbroeck, Katrien ;
Calin, George A. .
MIRNA AND CANCER, 2017, 135 :119-149
[40]   PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53 [J].
Wang, Wuyi ;
Wei, Jinlai ;
Zhang, Hairong ;
Zheng, Xiangru ;
Zhou, He ;
Luo, Yajun ;
Yang, Jianguo ;
Deng, Qican ;
Huang, Siqi ;
Fu, Zhongxue .
CELL DEATH & DISEASE, 2021, 12 (06)